HBM Holdings Limited (HKG:2142)
Hong Kong · Delayed Price · Currency is HKD 14.10
+0.30 (2.17%)
Nov 20, 2025, 4:08 PM HKT
HBM Holdings Market Cap
HBM Holdings has a market cap or net worth of 12.27 billion as of November 20, 2025. Its market cap has increased by 1,258.82% in one year.
Market Cap
12.27B
Enterprise Value
10.27B
Revenue
908.35M
Ranking
n/a
PE Ratio
19.50
Stock Price
14.10
Market Cap Chart
Since December 10, 2020, HBM Holdings's market cap has increased from 8.46B to 12.27B, an increase of 45.06%. That is a compound annual growth rate of 7.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2025 | 12.27B | 800.94% |
| Dec 31, 2024 | 1.36B | -3.91% |
| Dec 29, 2023 | 1.42B | -32.16% |
| Dec 30, 2022 | 2.09B | -63.14% |
| Dec 31, 2021 | 5.67B | -30.06% |
| Dec 31, 2020 | 8.11B | -4.17% |
| Dec 10, 2020 | 8.46B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 313.45B |
| Hansoh Pharmaceutical Group Company | 235.14B |
| JD Health International | 214.82B |
| Innovent Biologics | 153.63B |
| WuXi Biologics | 130.96B |
| Sino Biopharmaceutical | 124.42B |
| Akeso | 102.98B |
| Sichuan Kelun-Biotech Biopharmaceutical | 99.99B |